- Home
- INVH vs FMS Comparison
INVH vs FMS Comparison
Compare INVH & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVH
- FMS
- Stock Information
- Founded
- INVH 2012
- FMS 1996
- Country
- INVH United States
- FMS Germany
- Employees
- INVH N/A
- FMS N/A
- Industry
- INVH Real Estate
- FMS Misc Health and Biotechnology Services
- Sector
- INVH Finance
- FMS Health Care
- Exchange
- INVH Nasdaq
- FMS Nasdaq
- Market Cap
- INVH 18.5B
- FMS 15.0B
- IPO Year
- INVH 2017
- FMS 1996
- Fundamental
- Price
- INVH $29.63
- FMS $25.58
- Analyst Decision
- INVH Buy
- FMS Sell
- Analyst Count
- INVH 15
- FMS 2
- Target Price
- INVH $36.70
- FMS $30.00
- AVG Volume (30 Days)
- INVH 3.5M
- FMS 306.8K
- Earning Date
- INVH 10-29-2025
- FMS 11-04-2025
- Dividend Yield
- INVH 3.91%
- FMS 2.23%
- EPS Growth
- INVH 14.19
- FMS 23.39
- EPS
- INVH 0.89
- FMS 2.62
- Revenue
- INVH $2,647,487,000.00
- FMS $22,922,038,756.00
- Revenue This Year
- INVH $5.42
- FMS $2.10
- Revenue Next Year
- INVH $3.66
- FMS $3.13
- P/E Ratio
- INVH $33.42
- FMS $19.38
- Revenue Growth
- INVH 5.09
- FMS 0.53
- 52 Week Low
- INVH $29.37
- FMS $18.94
- 52 Week High
- INVH $36.79
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- INVH 39.95
- FMS 54.70
- Support Level
- INVH $29.91
- FMS $24.66
- Resistance Level
- INVH $30.65
- FMS $25.33
- Average True Range (ATR)
- INVH 0.54
- FMS 0.32
- MACD
- INVH -0.06
- FMS 0.10
- Stochastic Oscillator
- INVH 12.82
- FMS 82.62
About INVH Invitation Homes Inc.
Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with almost 70% of the portfolio in the Western U.S. and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.